Keywords
Covishield, Guillain-Barré syndrome, GBS, AstraZeneca, Coronavirus, pandemic, vaccine, ChAdOx1
Abstract
Various vaccines against COVID-19 have been developed since SARS-CoV-2 emerged at the end of 2019. Their emergency administration in healthcare settings has been accompanied by numerous adverse effects. A case of Guillain-Barré syndrome following vaccination with Covishield is presented here to highlight this possible adverse condition.
References
Views: 1217
HTML downloads: 127
PDF downloads: 438
Published:
2021-10-08
Issue:
2021: Vol 8 No 9
(view)